Chairman of the Board, CEOMr. Bruce C. Cozadd is a Chairman of the Board, Chief Executive Officer of Jazz Pharmaceuticals PLC. He has served as our Chairman and Chief Executive Officer since the closing of the Azur Merger in January 2012. He cofounded Jazz Pharmaceuticals, Inc. and has served as Chairman and Chief Executive Officer of Jazz Pharmaceuticals, Inc. since April 2009. From 2003 until 2009, he served as Jazz Pharmaceuticals, Inc.s Executive Chairman and as a member of its board of directors. From 1991 until 2001, he held various positions with ALZA Corporationrationration, a pharmaceutical company acquired by Johnson Johnson, most recently as Executive Vice President and Chief Operating Officer, with responsibility for research and development, manufacturing and sales and marketing. Previously at ALZA Corporationrationration, he held the roles of Chief Financial Officer and Vice President, Corporationrationrate Planning and Analysis. He serves on the boards of directors and compensation committees of Cerus Corporationrationration, a biomedical products company, and Threshold Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, and on the boards of The Nueva School, a nonprofit organization, and SFJAZZ, a nonprofit organization. He received a B.S. from Yale University and an M.B.A. from the Stanford Graduate School of Business. As our Chief Executive Officer, he brings to our board of directors a detailed knowledge of our business.
Age: 52 Chairman Since 2009 MBA